Stay updated with breaking news from Nasdaq Alt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Guggenheim downgraded shares of Altimmune (NASDAQ:ALT – Free Report) from a buy rating to a neutral rating in a research note released on Monday, Marketbeat reports. Several other analysts have also commented on the stock. B. Riley reaffirmed a buy rating and issued a $20.00 price objective on shares of Altimmune in a research report […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) shot up 6.5% during trading on Monday . The stock traded as high as $7.37 and last traded at $7.36. 1,032,095 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 5,444,214 shares. The stock had previously closed at $6.91. Analyst Upgrades […]
Altimmune (NASDAQ:ALT – Free Report) had its price target reduced by HC Wainwright from $15.00 to $12.00 in a research note released on Monday, Benzinga reports. They currently have a buy rating on the stock. ALT has been the subject of a number of other research reports. The Goldman Sachs Group initiated coverage on shares […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) traded up 5.3% on Thursday . The company traded as high as $9.38 and last traded at $9.36. 660,352 shares changed hands during trading, a decline of 89% from the average session volume of 5,935,036 shares. The stock had previously closed at $8.89. Analyst Ratings Changes A number […]
Connective Portfolio Management LLC acquired a new stake in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) in the fourth quarter, Holdings Channel reports. The firm acquired 16,000 shares of the company’s stock, valued at approximately $180,000. Several other hedge funds have also recently modified their holdings of ALT. FNY Investment Advisers LLC purchased a […]